Indivior PLC (INDV) Tops Q4 EPS by 15c ; Offers Guidance Feb 26, 2026 08:01AM
Indivior completes move from UK to US incorporation Jan 26, 2026 07:00AM
Indivior (INDV) PT Raised to $48 at H.C. Wainwright Jan 12, 2026 06:50AM
Indivior (INDV) PT Raised to $50 at Craig-Hallum Jan 9, 2026 09:26AM
Indivior provides 2026 financial guidance with revenue up to $1.195 billion Jan 8, 2026 07:04AM


Dec 17, 2025 11:30AM Indivior study finds higher SUBLOCADE dose aids fentanyl users
Dec 5, 2025 05:20PM S&P announces index changes affecting dozens of companies across three indices
Nov 20, 2025 04:01PM Indivior pays $295 million to conclude DOJ matter
Nov 3, 2025 08:04AM Indivior presents data on monthly injectable buprenorphine benefits
Oct 30, 2025 07:50AM Indivior PLC (INDV) Tops Q3 EPS by 33c ; Offers Guidance
Oct 15, 2025 08:04AM SUBLOCADE study shows higher retention rates with rapid induction method
Oct 1, 2025 08:02AM Indivior plans move from UK to US through new Delaware parent company
Aug 27, 2025 09:04AM Indivior (INDV) PT Raised to $34 at Craig-Hallum
Aug 27, 2025 08:47AM Piper Sandler Reiterates Overweight Rating on Indivior (INDV)
Jul 31, 2025 07:24AM Indivior PLC (INDV) Tops Q2 EPS by 27c; raises guidance
Jul 22, 2025 02:52AM Jefferies Assumes Indivior (INDV) at Buy
Jun 24, 2025 04:13PM Indivior (INDV) adds Tony Kingsley to Board
May 27, 2025 08:30AM Indivior (INDV) names Patrick Barry as CCO
Apr 25, 2025 04:22PM Indivior PLC (INDV) Tops Q1 EPS by 16c
Mar 4, 2025 08:41AM Indivior (INDV) Announces Board Changes
Feb 20, 2025 07:46AM Indivior PLC (INDV) Tops Q4 EPS by 6c, Offers Guidance
Jan 28, 2025 06:45AM Rodman & Renshaw Starts Indivior (INDV) at Buy
Oct 30, 2024 12:33PM Indivior (INDV) Highlights Growing Body of Data on SUBLOCADE
Oct 25, 2024 08:59AM Indivior (INDV) PT Raised to $16 at Piper Sandler
Oct 11, 2024 07:58AM Piper Sandler Reiterates Overweight Rating on Indivior (INDV)
Oct 10, 2024 07:02AM Indivior (INDV) Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance
Oct 7, 2024 11:36AM Indivior's (INDV) SUBLOCADE Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review
Sep 23, 2024 09:34AM Indivior (INDV) PT Lowered to $20 at Craig-Hallum
Sep 13, 2024 07:26AM Piper Sandler Reiterates Overweight Rating on Indivior (INDV)
Aug 26, 2024 10:30AM Indivior (INDV) Announces BARDA's First Order of OPVEE to Combat Opioids and Aid in National Preparedness
Jul 25, 2024 05:54AM Indivior (INDV) Announces New $100M Share Buyback
Jul 23, 2024 03:17AM Piper Sandler Starts Indivior (INDV) at Overweight
Jul 10, 2024 08:51AM Indivior (INDV) PT Lowered to $24 at Craig-Hallum
Jul 9, 2024 07:10AM Indivior (INDV) lowers guidance